Ticker

Analyst Price Targets — CMT

Page 1 • Showing up to 10
DateAnalystFirmTargetPrice @ PostSourceHeadline
March 11, 2026 12:16 pmChip MooreRoth Capital$24.00$18.48TheFly Core Molding price target raised to $24 from $22 at Roth Capital
March 12, 2025 12:02 pmChip MooreRoth Capital$22.00$13.32TheFly Core Molding price target lowered to $22 from $24 at Roth MKM
March 13, 2024 7:07 amTim MooreEF Hutton$27.00$19.19StreetInsider Core Molding Technologies (CMT) PT Raised to $27 at EF Hutton

Latest News for CMT

Core Molding Technologies Announces Timing of Its Fiscal 2026 Second Quarter Results

COLUMBUS, Ohio, July 14, 2026 (GLOBE NEWSWIRE) -- Core Molding Technologies, Inc. (NYSE American: CMT) (“Core Molding”, “Core” or the “Company”), a leading engineered materials company specializing in molded structural products, principally in medium- and heavy-duty trucks, powersports, building products, and industrial and utility industries across North America, today announces that it will release its second…

GlobeNewsWire • Jul 14, 2026
Core Molding Technologies Extends Credit Facility Through 2031, Increasing Financial Flexibility for Strategic Growth

COLUMBUS, Ohio, July 07, 2026 (GLOBE NEWSWIRE) -- Core Molding Technologies, Inc. (NYSE American: CMT) (“Core Molding”, “Core” or the “Company”), a leading engineered materials company specializing in molded structural products, principally in medium- and heavy-duty truck, powersports, building products, and industrial and utility industries across the United States, Canada, and Mexico, today announced the…

GlobeNewsWire • Jul 7, 2026
SYNAPSE-CMT Phase 2a Clinical Study Data Presented in Late-Breaking Oral Presentation at 2026 PNS Annual Meeting

Aarhus, Denmark, 17 June 2026 – NMD Pharma A/S, a clinical-stage biotechnology company dedicated to developing novel therapies to restore skeletal muscle health, today announces that further safety and efficacy data from its Phase 2a SYNAPSE-CMT exploratory study evaluating ignaseclant in patients living with Charcot-Marie-Tooth disease (CMT) types 1 or 2 has been presented in a late-breaking oral presentation at…

GlobeNewsWire • Jun 17, 2026
Cullinan Metals Launches New Corporate Website and Announces Strategic Repositioning

VANCOUVER, BC – TheNewswire - June 01, 2026 – Cullinan Metals Corp. (the “Company”) (CSE: CMT) (OTCQB: CNTMF) (FSE: 7KO) is pleased to announce the launch of its new corporate website, reflecting the Company's evolving strategic direction and renewed focus on emerging resource opportunities and advanced technologies. The new website is now available at: www.cullinanmetalscorp.com

TheNewswire • Jun 1, 2026
Core Molding Technologies Looks For A Good 2026/2027 But Remains Aggressively Priced

Core Molding Technologies reported 1Q26 results showing pressured trucking revenues offset by strength in industrial, EV, and BESS segments. CMT maintains robust gross margins (~20%) and expects 17–19% for the year, with adjusted operating income potentially reaching $20 million in 2026. Management anticipates a trucking cycle recovery and sales upside from the expanded Matamoros facility in 2H26, but near-term…

Seeking Alpha • May 28, 2026

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for CMT.

No House trades found for CMT.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top